Quantitative and qualitative data from our AI-powered computational platform enhances cytology insights to improve workflows and quality of patient care in the battle against cancer.
Feedback from pathology partners using AI-assisted cytology workflows.
“AIxURO has become a valued part of how our cytology team approaches AI-assisted case review.”
“AIxURO gives our pathology team a practical way to bring consistency, structure, and efficiency to cytology review workflows.”
“AIxURO provides valuable support for our evaluation of AI-assisted urological cytology workflows. The platform is easy to use and helps our team review and organize cytology data in a more structured way. In a short time, AIxURO has become a useful tool for exploring how AI can support laboratory workflow efficiency.”
AIxMed supports cytology review with automated prioritization, standardized data, and structured assisted workflows.
Our digital cytology platform targets devastating cancers — starting with bladder, and expanding across thyroid, cervical, and lung.
TMAIxURO analyzes and categorizes suspicious and atypical cells using a non-invasive urine sample.
AIxTHY: AI-powered analysis platform for thyroid cytology.
AIxPAP: Cervical cancer is preventable but remains a major health challenge.
AIxPUL: AI-powered analysis platform for pulmonary cytology.
